• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿茶酚胺能多形性室性心动过速

Catecholaminergic Polymorphic Ventricular Tachycardia.

作者信息

Lieve Krystien V, van der Werf Christian, Wilde Arthur A

机构信息

Heart Centre, Department of Clinical and Experimental Cardiology, Academic Medical Centre.

出版信息

Circ J. 2016 May 25;80(6):1285-91. doi: 10.1253/circj.CJ-16-0326. Epub 2016 May 13.

DOI:10.1253/circj.CJ-16-0326
PMID:27180891
Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited cardiac arrhythmia disorder that is characterized by emotion- and exercise-induced polymorphic ventricular arrhythmias and may lead to sudden cardiac death (SCD). CPVT plays an important role in SCD in the young and therefore recognition and adequate treatment of the disease are of vital importance. In the past years tremendous improvements have been made in the diagnostic methods and treatment of the disease. In this review, we summarize the clinical characteristics, genetics, and diagnostic and therapeutic strategies of CPVT and describe the most recent advances and some of the current challenges. (Circ J 2016; 80: 1285-1291).

摘要

儿茶酚胺能多形性室性心动过速(CPVT)是一种遗传性心律失常疾病,其特征为情绪和运动诱发的多形性室性心律失常,并可能导致心源性猝死(SCD)。CPVT在年轻人的心源性猝死中起重要作用,因此对该疾病的识别和适当治疗至关重要。在过去几年中,该疾病的诊断方法和治疗取得了巨大进展。在本综述中,我们总结了CPVT的临床特征、遗传学以及诊断和治疗策略,并描述了最新进展和当前的一些挑战。(《循环杂志》2016年;80: 1285 - 1291)

相似文献

1
Catecholaminergic Polymorphic Ventricular Tachycardia.儿茶酚胺能多形性室性心动过速
Circ J. 2016 May 25;80(6):1285-91. doi: 10.1253/circj.CJ-16-0326. Epub 2016 May 13.
2
[Catecholaminergic polymorphic ventricular tachycardia; possible diagnosis in cases of syncope and sudden death of family members].[儿茶酚胺能多形性室性心动过速;家庭成员晕厥和猝死病例的可能诊断]
Ned Tijdschr Geneeskd. 2015;159:A8205.
3
Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT).长 QT 综合征(LQTS)、Brugada 综合征和儿茶酚胺多形性室性心动过速(CPVT)中的心源性猝死。
Prog Cardiovasc Dis. 2019 May-Jun;62(3):227-234. doi: 10.1016/j.pcad.2019.05.006. Epub 2019 May 9.
4
Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies.儿茶酚胺敏感性多形性室性心动过速:治疗策略综述。
Card Electrophysiol Clin. 2023 Sep;15(3):293-305. doi: 10.1016/j.ccep.2023.04.002. Epub 2023 Jun 20.
5
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.
6
Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia.儿茶酚胺能多形性室性心动过速的临床挑战
Heart Lung Circ. 2016 Aug;25(8):777-83. doi: 10.1016/j.hlc.2016.01.012. Epub 2016 Feb 16.
7
Exercise testing oversights underlie missed and delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia in young sudden cardiac arrest survivors.运动试验的疏忽是导致年轻心搏骤停幸存者儿茶酚胺多形性室性心动过速漏诊和延误诊断的原因之一。
Heart Rhythm. 2019 Aug;16(8):1232-1239. doi: 10.1016/j.hrthm.2019.02.012. Epub 2019 Feb 11.
8
[Clinical challenges in the management of catecholaminergic polymorphic ventricular tachycardia in children].[儿童儿茶酚胺能多形性室性心动过速管理中的临床挑战]
Zhonghua Er Ke Za Zhi. 2017 Dec 2;55(12):926-931. doi: 10.3760/cma.j.issn.0578-1310.2017.12.012.
9
Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.致心律失常性右室心肌病相关的心脏兰尼碱受体基因突变导致儿茶酚胺敏感性多形性室性心动过速的临床和分子特征。
Heart Rhythm. 2015 Jul;12(7):1636-43. doi: 10.1016/j.hrthm.2015.03.033. Epub 2015 Mar 23.
10
Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.氟卡尼治疗可抑制 CASQ2 相关儿茶酚胺敏感性多形性室性心动过速患者运动诱发的室性心律失常。
Heart Rhythm. 2013 Nov;10(11):1671-5. doi: 10.1016/j.hrthm.2013.08.011. Epub 2013 Aug 13.

引用本文的文献

1
Identification of Mutations of the in Sudden Infant Death Syndrome.婴儿猝死综合征中基因的突变鉴定
J Korean Med Sci. 2025 Feb 17;40(6):e17. doi: 10.3346/jkms.2025.40.e17.
2
Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans.肌醇1,4,5-三磷酸受体1功能获得性突变增加小鼠和人类发生心律失常的风险。
Circulation. 2025 Mar 25;151(12):847-862. doi: 10.1161/CIRCULATIONAHA.124.070563. Epub 2024 Dec 10.
3
Sudden Cardiac Death and Channelopathies: What Lies behind the Clinical Significance of Rare Splice-Site Alterations in the Genes Involved?
心脏性猝死和通道病:涉及的基因中罕见剪接位点改变的临床意义背后是什么?
Genes (Basel). 2024 Sep 27;15(10):1272. doi: 10.3390/genes15101272.
4
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.《日本循环学会/日本心律学会2022年心律失常诊断与风险评估指南》
J Arrhythm. 2024 Jun 12;40(4):655-752. doi: 10.1002/joa3.13052. eCollection 2024 Aug.
5
Catheter Ablation for Channelopathies: When Is Less More?通道病的导管消融治疗:少即是多?何时如此?
J Clin Med. 2024 Apr 19;13(8):2384. doi: 10.3390/jcm13082384.
6
Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies.儿茶酚胺能多形性室性心动过速:临床特征、诊断评估与治疗策略
J Clin Med. 2024 Mar 20;13(6):1781. doi: 10.3390/jcm13061781.
7
RYR2-ryanodinopathies: from calcium overload to calcium deficiency.RYR2-ryanodinopathies:从钙超载到钙缺乏。
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad156.
8
Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS/BACH1 axis.兰尼碱受体 2 通过 ROS/BACH1 轴促进结直肠癌转移。
Mol Oncol. 2023 Apr;17(4):695-709. doi: 10.1002/1878-0261.13350. Epub 2022 Dec 21.
9
Clinical Characteristics, Genetic Findings and Arrhythmic Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia from China: A Systematic Review.中国儿茶酚胺能多形性室性心动过速患者的临床特征、遗传学发现及心律失常结局:一项系统评价
Life (Basel). 2022 Jul 22;12(8):1104. doi: 10.3390/life12081104.
10
Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery.用于疾病建模和药物发现的人源工程心脏组织模型
Front Cell Dev Biol. 2022 Mar 31;10:855763. doi: 10.3389/fcell.2022.855763. eCollection 2022.